Characterization of Notch1 Antibodies That Inhibit Signaling of Both Normal and Mutated Notch1 Receptors

Miguel Aste-Amézaga, Ningyan Zhang, Janet E. Lineberger et al. · 2010

Read Characterization of Notch1 Antibodies That Inhibit Signaling of Both Normal and Mutated Notch1 Receptors by Miguel Aste-Amézaga, Ningyan Zhang, Janet E. Lineberger et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0009094.txt.

Description

Miguel Aste-Amézaga and co-authors built antibodies that switch off a key development signal, in PLOS ONE in 2010. Notch receptors guide cell fate choices throughout animal development and growth. When Notch1 signalling runs out of control, several cancers can follow. The signal also feeds the growth of tumour blood vessels.

The team characterised antibodies that block Notch1's signal directly. The antibodies inhibited the normal receptor and mutated versions alike. Mutant receptors drive some leukaemias and can resist simpler blockers. A blocker covering both normal and mutant forms could serve as a cancer drug scaffold.

Catalog record

CREATORMiguel Aste-Amézaga, Ningyan Zhang, Janet E. Lineberger et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE65 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009094

Browse the full library · About the Tower of Babel